CLL is characterized by constitutive activation of BCR signaling pathways but with variable responsiveness to antigen ligation; associated with co-expression of CD38 via ZAP70 [8–10]. This evidence concerns the gene ZAP70 and B-cell chronic lymphocytic leukemia.